Semin Arthritis Rheu: Acute respiratory viral infection during rheumatic treatment.

!---- COVID-19 is an acute respiratory virus infection that poses a threat worldwide, including people with rheumatism.but the extent to which rheumatoid treatment increases susceptibility to viral respiratory infections is unclear.study reviewed the incidence and severity of acute respiratory virus adverse events associated with rheumatic therapy.use an online database to find research on the main data on acute respiratory virus infection in patients with anti-rheumatism treatment.independent reviewers use standardized extract tools to pair chart data for eligible studies. A total of 180 studiesmet the criteria for qualitative analysis.Although the available literature lacks specificity in reporting acute viral infections or their complications, the data show that the use of glucocorticoids, JAK inhibitors (especially in high doses), TNF inhibitors, and anti-IL-17 drugs is associated with an increased incidence of respiratory viral infections.available data show that the use of NSAIDs, serotonin, lyunine sulfonate, methotrexate, thiopental, milolofate, cyclophosphamide or apsteadoes does not increase the incidence or risk of respiratory virus events.a large cohort study, the use of lefluorometus is associated with an increased risk of acute viral respiratory events compared to non-use.the study found that certain drugs increase the risk of acute respiratory infections.however, the lack of precise data should address this knowledge gap in future studies..